Immediate Impact

1 from Science/Nature 52 standout
Sub-graph 1 of 22

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
2 intermediate papers

Works of Xiaojiao Ban being referenced

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway
2019

Author Peers

Author Last Decade Papers Cites
Xiaojiao Ban 324 206 3 68 8 402
Lei Li 259 237 2 70 11 388
M M Vleugel 298 250 1 135 6 442
Qingqiang Dai 257 265 44 9 367
Sujin Yim 322 227 1 51 9 436
Li Luo 217 159 1 77 7 361
Jiaomeng Pan 232 212 49 8 336
Jia Liu 274 274 49 9 371
Shu Zhang 297 196 4 84 7 401
Chandrika Jeyamohan 221 143 88 9 349
Hong Wu 287 203 60 9 415

All Works

Loading papers...

Rankless by CCL
2026